The COVID-19 rapid antibody test, developed by Abingdon Health, the lead in the UK-Rapid Test Consortium (UK-RTC), has received its CE mark.
Learn how our multi-disciplinary approach and precision manufacturing assures security of supply for the most complex of assays and markets
Abingdon Health is delighted to announce the UK-RTC has reached design freeze for the AbC-19TM lateral flow test.
Learn how lateral flow can work with Isothermal amplification methods or PCR to expedite your route to market without the need for expensive equipment or extensive training.
Abingdon Health is mobilising its rapid test operations in response to the COVID-19 outbreak and recruiting in several areas. Learn more.